Does Azilsartan Medoximil – Chlorthalidone Lower Risk of Coronary Heart Disease Than Olmesartan Medoximil – Hydrochlorthiazide In Patients With Essential Hypertension- A Cost-Effective Analysis
May 1, 2015, 00:00
10.1016/j.jval.2015.03.832
https://www.valueinhealthjournal.com/article/S1098-3015(15)00889-X/fulltext
Title :
Does Azilsartan Medoximil – Chlorthalidone Lower Risk of Coronary Heart Disease Than Olmesartan Medoximil – Hydrochlorthiazide In Patients With Essential Hypertension- A Cost-Effective Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)00889-X&doi=10.1016/j.jval.2015.03.832
First page :
A143
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
274